Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
40 studies found for:    "Hepatitis, Alcoholic"
Show Display Options
Rank Status Study
21 Recruiting Effects of Prednisolone and Pentoxifylline on the Regulation of Urea Synthesis in Alcoholic Hepatitis
Condition: Alcoholic Hepatitis
22 Recruiting Efficacy and Safety of MG in the Patients With Alcoholic Fatty Liver Disease and Alcoholic Hepatitis
Conditions: Alcoholic Fatty Liver Disease;   Alcoholic Hepatitis
Interventions: Drug: Placebo /bid P.O;   Drug: MG-1;   Drug: MG-2 : MG1000mg, Placebo  /bid P.O;   Drug: metadoxine
23 Not yet recruiting A Safety and Efficacy Study of Mycophenolate Mofetil and Rilonacept in Patients With Alcoholic Hepatitis
Condition: Alcoholic Hepatitis
Interventions: Drug: Rilonacept;   Drug: Mycophenolate mofetil;   Drug: Prednisolone
24 Completed Intensive Enteral Nutrition and Acute Alcoholic Hepatitis
Condition: Severe Alcoholic Hepatitis
Interventions: Dietary Supplement: intensive nutrition;   Dietary Supplement: usual meals
25 Recruiting Efficacy of G-CSF in the Management of Steroid Non-responsive Severe Alcoholic Hepatitis
Condition: Severe Alcoholic Hepatitis
Interventions: Drug: G-CSF;   Drug: Placebo
26 Enrolling by invitation Short-term Survival in Patients With Severe Alcoholic Hepatitis Treated With Steroid Versus Pentoxifylline
Condition: Alcoholic Hepatitis
Interventions: Drug: pentoxifylline;   Drug: Prednisolone
27 Recruiting Study of IDN-6556 in Patients With Severe AH and Contradictions to Steroid Therapy
Condition: Alcoholic Hepatitis
Intervention: Drug: IDN-6556
28 Withdrawn Treatment of Alcohol-Related Hepatitis With Arginine
Condition: Alcoholic Hepatitis
Intervention: Drug: Arginine
29 Active, not recruiting Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLF
Conditions: Acute on Chronic Hepatic Failure;   Acute Liver Failure;   Liver Cirrhosis;   Acute Alcoholic Hepatitis
Intervention: Drug: IDN-6556
30 Recruiting Assess Safety and Efficacy of ELAD (Extracorporeal Liver Assist System) in Subjects With Alcohol-Induced Liver Failure
Condition: Acute Alcoholic Hepatitis
Interventions: Biological: ELAD  treatment;   Other: Standard of care (Control)
31 Recruiting A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area
Conditions: Carcinoma, Hepatocellular;   Liver Cirrhosis, Alcoholic;   Hepatitis, Alcoholic;   Hepatitis, Chronic;   Hepatitis, Viral, Human
32 Completed Randomized, Controlled Trial of S-adenosylmethionine in Alcoholic Liver Disease
Condition: Alcoholic Hepatitis
Interventions: Other: Placebo;   Dietary Supplement: SAMe
33 Completed Adipose Tissue Involvement in Alcohol-induced Liver Inflammation in Human
Conditions: Alcoholic Hepatitis;   Alcoholic Cirrhosis
Intervention: Other: blood and biopsies
34 Completed Prognostic Indicators as Provided by the EPIC ClearView
Conditions: Coronary Artery Disease;   Congestive Heart Failure;   Valvular Heart Disease;   Atrial Fibrillation;   Hypertension;   Pyelonephritis;   Acute Renal Failure;   Renal Failure;   Viral Hepatitis;   Alcoholic Hepatitis;   Steatohepatitis;   Cirrhosis;   Asthma;   COPD;   Bronchitis;   Emphysema;   Pneumonia;   Inflammatory Bowel Disease;   Crohn's Disease;   Ulcerative Colitis;   Diverticulitis;   Peptic Ulcer Disease;   Irritable Bowel Syndrome;   Cholecystitis;   Pancreatitis;   Malabsorption Disorders;   Celiac Sprue;   Diabetes
35 Recruiting The Effect of High Dose Vitamin C on the Liver Function in Chronic Hepatitis Patients
Conditions: Chronic Hepatitis;   Chronic Hepatitis C;   Chronic Alcoholic Hepatitis
Intervention: Drug: High dose vitamin C
36 Recruiting Immune Cell Dysfunction in Severe Alcoholic Hepatitis
Condition: Hepatitis
37 Unknown  Granulocyte Colony Stimulating Factor (G-CSF) in Acute Liver Failure and Alcoholic Hepatitis
Condition: Liver Failure, Acute
Intervention: Drug: Granulocyte colony stimulating factor
38 Completed Trial for Hepatocellular Carcinoma Adjuvant Treatment by Lipiocis
Conditions: Carcinoma, Hepatocellular;   Hepatitis, Viral, Human
Intervention: Drug: 131 I-lipiodol
39 Withdrawn Registry Protocol for Tracking Trial Subjects After VTI-206 Study Completion
Condition: Acute Liver Failure
Intervention: Drug: ELAD (Extracorporeal Liver Assist System)
40 Completed A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Condition: Hepatorenal Syndrome Type 1
Interventions: Drug: Terlipressin;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page   
Indicates status has not been verified in more than two years